Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

Premium
Credit: Reuters

Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.